NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin
key details
| Value | £1,200,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33651520 |
| Deadline | 26 Feb 2021 |
| Procedure | open |
| OCID | ocds-h6vhtk-028c7b |
Awards (8)
This procurement was awarded to 8 suppliers. Values shown are per-award; the notice total is £1,200,000,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| BIO PRODUCTS LABORATORY LIMITED shared | · | · | active |
| Bio Products Laboratory Ltd shared | · | · | active |
| Biotest UK Limited shared | · | · | active |
| CSL Behring UK Ltd shared | · | · | active |
| Grifols UK Ltd. shared | · | · | active |
| LFB shared | · | · | active |
| Octapharma Limited shared | · | · | active |
| Shire Pharmaceuticals Ltd shared | · | · | active |
description
National Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin. The framework will commence on 1 July 2021 for a period of 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.
notice history
12 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 22 Jan 2021 | Contract notice (F02) | Earlier regulations | 001317-2021 |
| 22 Jul 2021 | Contract award notice (F03) | Earlier regulations | 017380-2021 |
| 13 Dec 2024 | Modification notice (F20) | Earlier regulations | 040318-2024 |
| 16 Dec 2024 | Modification notice (F20) | Earlier regulations | 040398-2024 |
| 16 Dec 2024 | Modification notice (F20) | Earlier regulations | 040395-2024 |
| 16 Dec 2024 | Modification notice (F20) | Earlier regulations | 040406-2024 |
| 16 Dec 2024 | Modification notice (F20) | Earlier regulations | 040401-2024 |
| 16 Dec 2024 | Modification notice (F20) | Earlier regulations | 040404-2024 |
| 16 Dec 2024 | Modification notice (F20) | Earlier regulations | 040403-2024 |
| 16 Dec 2024 | Modification notice (F20) | Earlier regulations | 040405-2024 |
| 16 Dec 2024 | Modification notice (F20) | Earlier regulations | 040400-2024 |
| 16 Dec 2024 | Modification notice (F20) | Earlier regulations | 040399-2024 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- NHS Framework Agreement for the supply of Human Immunoglobulin and Anti-D Immunoglobulin · NHS ENGLAND
- SUPPLY OF BOTULISM ANTITOXIN HEPTEVALENT (HBAT) · Ministry of Defence
- SARS-CoV-2 Nucleocapsid proteins for LFT Revalidation and Testing · UK Health Security Agency · £500,000
- CMU Framework for the supply of Anti-D Immunoglobulin · University Hospitals of Leicester NHS Trust · £209,801
- PHE_Scientific Provision for purchase of the Euroimmun Anti SARS CoV 2 IgG assay · Public Health England · £158,400
- NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga) · The NHS Commissioning Board (operating under the name of NHS England)
- 1LHE Goods - Antibodies · NEWCASTLE UNIVERSITY · £25,115
- Contract for the provision of a Homecare Delivery Service for Immunoglobulins · The Newcastle upon Tyne Hospitals NHS Foundation Trust · £5,600,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.